Biogen Idec, Inc. (BIIB) Tops Q3 Adj-EPS by 8c
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $225.36 +2.87%
EPS Growth %: -57.8%
Financial Fact:
Other: 98.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -57.8%
Financial Fact:
Other: 98.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.61, ex-items, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.27 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone beats profit view but misses on revenue
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
Earnings, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
